Murray Richard
- SEC CIK
- 0001242935
No open-market purchases or sales filed in the past year.
Current role at each company
- JNCE Jounce Therapeutics, Inc.Directoras of May 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Murray Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Murray RichardDirector | SSale | −39.2K | $1.85 | −$72.6K | −17.2%188.8K after | 10b5-1 |
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Murray RichardCEO and President | SSale | −45.1K | $1.11 | −$50.1K | −16.5%228.0K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Murray RichardCEO and President | SSale | −37.3K | $6.88 | −$256.7K | −16.7%185.6K after | 2 lots |